Follow-up care for survivors of breast and prostate cancer


Breast cancer has been diagnosed and treated in approximately 2 million women living in the United States, and the incidence of prostate cancer—now second in prevalence to lung cancer in men—has shown a slow but steady increase.1 Cancers of the breast and prostate are hormone-dependent, and this has been the focus of intense research that has resulted in the new, effective adjuvant therapies that are in use today.

Related Content
© 2024 MJH Life Sciences

All rights reserved.